Ignite Creation Date:
2025-12-24 @ 5:57 PM
Ignite Modification Date:
2026-01-04 @ 4:06 PM
Study NCT ID:
NCT01355068
Status:
COMPLETED
Last Update Posted:
2021-01-28
First Post:
2011-05-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-12
First Submit QC Date:
None
Study First Post Date:
2011-05-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-11-10
Results First Submit QC Date:
None
Results First Post Date:
2011-12-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-26
Last Update Post Date:
2021-01-28
Last Update Post Date Type:
ACTUAL